These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34830633)
61. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX. Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871 [TBL] [Abstract][Full Text] [Related]
62. Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability. Lawson PJ; Moore HB; Moore EE; Gerich ME; Stettler GR; Banerjee A; Schulick RD; Nydam TL J Surg Res; 2018 Nov; 231():54-61. PubMed ID: 30278969 [TBL] [Abstract][Full Text] [Related]
63. The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study. Neethling C; Calligaro G; Miller M; Opie JJS Thromb J; 2021 Nov; 19(1):83. PubMed ID: 34742307 [TBL] [Abstract][Full Text] [Related]
64. The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease. Habe K; Wada H; Mizutani K; Matsushima Y; Kondo M; Yamanaka K Clin Rheumatol; 2021 Nov; 40(11):4675-4683. PubMed ID: 34136970 [TBL] [Abstract][Full Text] [Related]
65. Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death. Posch F; Hofer S; Thaler J; Hell L; Königsbrügge O; Grilz E; Mauracher LM; Gebhart J; Marosi C; Jilma B; Pabinger I; Ay C Transl Res; 2020 Jan; 215():41-56. PubMed ID: 31525325 [TBL] [Abstract][Full Text] [Related]
66. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis. Potze W; Adelmeijer J; Porte RJ; Lisman T Thromb Res; 2015 May; 135(5):1012-6. PubMed ID: 25746364 [TBL] [Abstract][Full Text] [Related]
68. Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event. Abdullah WZ; Moufak SK; Yusof Z; Mohamad MS; Kamarul IM Transl Res; 2010 Jun; 155(6):315-9. PubMed ID: 20478546 [TBL] [Abstract][Full Text] [Related]
69. A Novel Assessment of Factor VIII Activity by Template Matching Utilizing Weighted Average Parameters from Comprehensive Clot Waveform Analysis. Shimonishi N; Ogiwara K; Oda Y; Kawabe T; Okazaki S; Shima M; Nogami K Thromb Haemost; 2021 Feb; 121(2):164-173. PubMed ID: 32828071 [TBL] [Abstract][Full Text] [Related]
70. Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXa. Plautz WE; Chattopadhyay R; Goldfeld EI; Samelson-Jones BJ; Pilli VS; Campello E; Datta A; Arruda VR; Simioni P; Majumder R Thromb Res; 2018 Oct; 170():133-141. PubMed ID: 30189336 [TBL] [Abstract][Full Text] [Related]
71. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling. Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717 [TBL] [Abstract][Full Text] [Related]
72. The First-Derivative Curve of the Coagulation Waveform Reveals the Cause of aPTT Prolongation. Shimomura D; Matsumoto T; Sugimoto K; Takata T; Kouno A; Shimada M; Matsuo S; Kamioka M Clin Appl Thromb Hemost; 2020; 26():1076029620978810. PubMed ID: 33372824 [TBL] [Abstract][Full Text] [Related]
73. Hypercoagulability in cancer patients grouped by syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine. Chen Y; Upur H; Zhong M; Aizezi R J Tradit Chin Med; 2014 Feb; 34(1):30-3. PubMed ID: 25102687 [TBL] [Abstract][Full Text] [Related]
74. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen. Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ J Androl; 2005; 26(1):146-52. PubMed ID: 15611579 [TBL] [Abstract][Full Text] [Related]
75. Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor. Matsumoto T; Wada H; Ohishi K; Yamashita Y; Ikejiri M; Katayama N Clin Appl Thromb Hemost; 2019; 25():1076029618824419. PubMed ID: 30808219 [No Abstract] [Full Text] [Related]
76. Epidurals in patients receiving thromboprophylaxis with unfractionated heparin three times a day: the value of activated partial thromboplastin time testing. Pace M; Koury K; Gulur P Anesth Analg; 2014 Nov; 119(5):1215-8. PubMed ID: 25225890 [TBL] [Abstract][Full Text] [Related]
77. Analysis of factor XIa, factor IXa and tissue factor activity in burn patients. Shupp JW; Prior SM; Jo DY; Moffatt LT; Mann KG; Butenas S Burns; 2018 Mar; 44(2):436-444. PubMed ID: 29032977 [TBL] [Abstract][Full Text] [Related]